HC2

(redirected from Hybrid Capture 2)
AcronymDefinition
HC2Hybrid Capture 2
References in periodicals archive ?
Study included ThinPrep, SurePath, Hybrid Capture 2 assay.
A comparison of the Roche Cobas HPV Test with the Hybrid Capture 2 Test for the detection of high-risk human papillomavirus genotypes.
Compari-son of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of Hybrid Capture 2 in population-based cervical cancer screening.
Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) tests in detecting High-Risk HPV genotypes in specimens from women with previous abnormal Pap smear results.
The last FDA-cleared molecular assay discussed in this article, will be the Hybrid Capture 2 High-Risk HPV DNA test by Qiagen, Inc.
Presently, the two assays most widely used for the detection of genital types are PCR with generic primers and the Hybrid Capture 2 assay (Digene Corp, Gaithersburg, MD, USA).
The cost of the Hybrid Capture 2 High-Risk HPV DNA Test varies, but Medicare reimbursement is around $50, a Digene spokesman said.
The cost of the Hybrid Capture 2 High Risk HPV DNA Test varies, but Medicare reimbursement is around $50, a Digene spokesman said.
Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
Product Name: Digene Hybrid Capture 2 High-Risk HPV DNA Test
Agreement between the AMPLICOR human papillomavirus test and the hybrid capture 2 assay in detection of High-Risk Human Papillomavirus and Diagnosis of Biopsy-Confirmed High Grade Cervical Disease.
27% tested positive for high-risk HPV using Hybrid Capture 2.